samples in Japan (Kawashiro et al., 2008) .
Other PBDEs (pentaBDE or octaBDE) are reported to be adverse effect to male reproduction Talsness et al., 2005) . Compared to these PBDEs (pentaBDE or octaBDE), decaBDE is considered to have low toxicity in male reproductive organs (Darnerud, 2003; Van der Ven et al., 2008) . Studies of male mice demonstrating that decaBDE affects testes morphology and sperm motility and induces sperm oxidative stress (Tseng et al., 2006 (Tseng et al., , 2011 suggest that decaBDE may have adverse effects on mouse testes. However, the molecular mechanisms underlying these effects have not yet been determined.
Cortactin (p80/p85) (CTTN), an F-actin-binding protein, is a key signaling molecule in many cellular processes including cell adhesion, migration, endocytosis, and tumor invasion and metastasis. CTTN phosphorylation is regulated by p60 Src tyrosine kinase (SRC) and extracellular signal-regulated kinase (ERK1/2 or p44/42 ERK) (Ammer and Weed, 2008) . Tyr phosphorylation of CTTN is considered to result in reduced actin polymerization (Fan et al., 2004) . In previous studies of ICR mice treated with the sex hormone antagonists flutamide and ICI 182.780, we observed disruption of apical ectoplasmic specialization (ES) in the testis along with decreased expression of CTTN and increased Tyr phosphorylation of CTTN, resulting in abnormal morphology of spermatids (Anahara et al., 2004 (Anahara et al., , 2006a (Anahara et al., and 2006b . We also confirmed that endocrine disrupting chemicals (EDCs) could reduce CTTN expression and increase CTTN Tyr phosphorylation (Anahara et al., 2006c) .
DecaBDE likely has an estrogenic effect (Tseng et al., 2008) . We hypothesized that decaBDE affects mouse testes by altering the expression and phosphorylation levels of CTTN in a manner similar to that of flutamide. To test this hypothesis, we examined the changes in the expression and phosphorylation levels of CTTN in male mice that were postnatally exposed to various concentrations of decaBDE. Because SRC and ERK1/2 regulate CTTN phosphorylation (Ammer and Weed, 2008) , we also investigated the changes in the expression and phosphorylation levels of SRC and p44/42 ERK in these mice.
MATERIALS AND METHODS

Reagents
DecaBDE was purchased from Wako Pure Chemical Industries (Osaka, Japan). All other reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise indicated.
Animals and experimental design
ICR male (n = 12) and female (n = 12) mice were purchased from Japan SLC (Shizuoka, Japan) and mated at 12 weeks of age. The pregnant dams were randomly divided into four groups. After birth, five male pups were selected from each litter. Using the subcutaneous injection method modified from Santti et al. (1991) , male pups in the decaBDE-exposed groups (0.025, 0.25, or 2.5 mg/kg body weight/day) and control group (corn oil only) were injected on postnatal days 1 to 5. The animals were housed under a 12-hr light-dark cycle at 24-26°C in a temperature-controlled room. CLEA rodent chow CE2 (CLEA Japan Inc., Tokyo, Japan) and water were provided ad libitum. The mice were sacrificed at 12 weeks of age by CO 2 euthanasia. All the experimental procedures were performed in accordance with the Chiba University Guide for the Care and Use of Laboratory Animals.
Measurements of body and reproductive organ weights and sperm count
After sacrifice, body, testicular, and epididymal weights were measured. Sperm count was performed according to the procedure described by Krisfalusi et al. (2006) with a few modifications. In briefly, the cauda epididymis of each animal was collected in PBS and was snipped. Sperm from the minced cauda epidydimis were allowed to swim into 1 ml PBS for 15 min at room temperature, followed by gently squeezing the cauda epidydmis to expel the sperm. The sperm were collected in 1.5-ml tubes and diluted with water (1:100 or 1:50 dilution). The sperm count of each sample was determined four times using a hemocytometer.
Histological analyses
Testes from control and decaBDE-exposed groups were removed, immediately fixed in Bouin's solution, washed, dehydrated in a graded ethanol series, and embedded in resin (Technovit 7100, Kulzer, Wehrheim, Germany). The samples were then sliced into 5-μm sections with a microtome and stained with hematoxylin and eosin (H&E). For counting the number of Sertoli and germ cells per seminiferous tubule, 10 round seminiferous tubules at stages IV to V per mouse were randomly selected and counted them from four different mice in each group. The number of Sertoli cells, spermatogonia, pachytene spermatocytes, round spermatids, and elongated spermatids per tubule were counted under a light microscope (BX51, Olympus Optical Co., Tokyo, Japan). Scanned digital images were analyzed with Adobe Photoshop software version 7.0 (Adobe Systems, San Jose, CA, USA). For counting abnormal cells per seminiferous tubule, 10 round seminif-erous tubules per mouse were selected at random, and we counted them from the four different mice in each group.
Western blot analyses
Testicular samples were added to lysis buffer (50 mM Tris-HCl [pH 7.4], 1% NP40, 0.25% sodium deoxycholate, 150 mM NaCl, and 1 mM EDTA-2Na + ) with protease and phosphatase inhibitors (1 mM PMSF, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 10 μg/ml pepstatin, 50 mM NaF, 1 mM Na 3 VO 4 , 10 mM sodium pyrophosphate, and 1 mM β-glycerophosphate). Then, samples were homogenized on ice and centrifuged at 21,000 × g for 20 min at 4°C. The supernatants were dissolved in 2 × SDS sample buffer (20% glycerol, 12% 2-mercaptoethanol, 4% SDS, 0.1% bromophenol blue, and 100 mM Tris-HCl [pH 6.8]) and applied to polyacrylamide gel electrophoresis.
Equal amounts (2 μg) of protein were applied per lane to 10% SDS-polyacrylamide gels. The gels were then transferred onto PVDF membranes (Immobilon-P, Millipore, Billerica, MA, USA) by semidry electrophoresis (ATTO Corporation, Osaka, Japan). The membranes were blocked for 1 hr with 5% skim milk in Tris-buffered saline containing 0.5% Tween 20 (TBS-T) or with 5% BSA in TBS-T and incubated at 4°C for 12 hr with primary antibodies to CTTN (1:1,000; Millipore), pY421 CTTN (1:500; Invitrogen, Life Technologies, Carlsbad, CA, USA), pS405 CTTN (1:500; Protea Biosciences, Morgantown, WV, USA), p44/42 MAPK (1:1,000; Cell Signaling Technology, Beverly, MA, USA), and phospho-p44/42 MAPK (Thr202/Thr204; 1:1,000; Cell Signaling Technology). The membranes were then washed with TBS-T and incubated for 1 hr at room temperature with 1:10,000 dilution of peroxidase-labeled secondary anti-mouse IgG or anti-rabbit IgG antibody (GE Healthcare, Little Chalfont, UK). Subsequently, the membranes were washed with TBS-T and visualized with the ECL western blotting detection system (GE Healthcare). Protein bands were quantified by densitometry using ImageJ software (National Institutes of Health, Bethesda, MD, USA).
To determine the phosphorylation levels of CTTN and p44/42 ERK, the membranes treated with the antibodies to pY421 or pS405 CTTN and phospho-p44/42 MAPK were stripped and reprobed with antibodies to CTTN or p44/42 MAPK, respectively. To confirm equal protein loading, the membranes were probed with antibody to α-tubulin (1:1,000 dilution). Antibodies to SRC (1:200 dilution; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and pY416 SRC (1:500 dilution; Calbiochem, San Diego, CA, USA) were used to examine the expression and phosphorylation levels of SRC.
Statistical analyses
Statistical analyses were performed by one-way ANOVA followed by Dunnett's test. All values are expressed as means ± standard deviation (S.D.) except cell counts. Values of cell counts are expressed as means ± standard error of mean (S.E.M.). And p < 0.05 was considered significant differences statistically.
RESULTS
Body and reproductive organ weights
As shown in Table 1 , the mean testicular weights were significantly lower in the 0.025 and 0.25 mg/kg decaBDE-exposed groups. Further, the mean epididymal weight in the 0.25 mg/kg decaBDE-exposed group was significantly lower. Interestingly, no significant differences in the mean body weight were noted among any of the decaBDE-exposed groups.
Sperm count
The sperm count for the 0.025 mg/kg decaBDEexposed group was significantly lower than that of the control group (Fig. 1) . The sperm count in the 0.25 mg/kg decaBDE-exposed group was 16% lower than that in the control group, but the difference was not significant.
Testicular histology
As shown in Table 2 , the numbers of Sertoli cells and elongated spermatids per seminiferous tubule was significantly lower in the 0.025 and 0.25 mg/kg decaBDEexposed groups. However, the incidence of these cell types examined did not differ in the 2.5 mg/kg decaBDEexposed group. Although we did not observe any abnormalities in testes morphology in the 0.025 mg/kg decaBDE-exposed group ( Fig. 2C ) compared to the control group (Figs. 2A-B), there were some abnormal germ cells or cells with densely stained nuclei in the seminiferous tubules from the 0.25 mg/kg and 2.5 mg/kg decaBDEexposed groups (Figs. 2D-F; arrows). In addition, the 2.5 mg/kg decaBDE-exposed group had a higher number of abnormal germ cells than the control group (Fig. 2G) ; however, this difference was not significant.
Expression and phosphorylation levels of CTTN
The expression level of pY421 CTTN in the 0.025 mg/ kg decaBDE-exposed group was 10% higher than the control group; however there was no significant difference. No significant differences were noted between the control and the decaBDE groups exposed to higher doses (0.25 and 2.5 mg/kg) (Fig. 3B) . The expression level of CTTN has no difference in the 0.025 mg/kg decaBDEexposed group and was significantly lower in the 0.25 and 2.5 mg/kg decaBDE-exposed groups (Fig. 3C ). The phosphorylation level of pY421 CTTN was significantly higher in all decaBDE-exposed groups (Fig. 3D) ; however, It appears that the 0.25 and 2.5 mg/kg decaBDE-exposed groups elevated pY421 CTTN phosphorylation level due to reduction of CTTN expression level.
The expression of pS405 CTTN was significantly higher in the 0.25 and 2.5 mg/kg decaBDE-exposed groups (Fig. 4B) . Further, the expression of CTTN was significantly lower in the 0.25 and 2.5 mg/kg decaBDE-exposed groups (Fig. 4C ). In addition, the phosphorylation level of pS405 CTTN was significantly higher in the 0.25 and 2.5 mg/kg decaBDE-exposed groups (Fig. 4D ).
Expression and phosphorylation levels of SRC
The expression level of pY416 SRC did not differ for any of the exposed groups compared to the control group (Fig. 5B) , while the expression level of SRC was significantly lower in the 0.025 and 0.25 mg/kg decaBDEexposed groups (Fig. 5C ). The phosphorylation level of pY416 SRC was significantly higher only in the 0.025 mg/kg decaBDE-exposed group (Fig. 5D ), however this appears to be caused by reduction of SRC expression level.
Expression and phosphorylation levels of p44/42 ERK (ERK1/2)
The expression level of phosho-p44/42 ERKs was significantly higher in the 2.5 mg/kg decaBDE-exposed group (Fig. 6B) . The expression level of p44/42 ERKs was significantly lower in the 0.25 and 2.5 mg/kg decaBDE-exposed groups (Fig. 6C) . The phosphorylation of p44/42 ERKs was significantly higher in only the 2.5 mg/kg decaBDE-exposed group (Fig. 6D) , while the phosphorylation of p44/42 ERKs in the other exposed groups (0.025 and 0.25 mg/kg) was slightly higher but not statistically significant (Fig. 6D) .
DISCUSSION
In the current study we found that, somewhat surprisingly, decaBDE exposure by subcutaneous injection on PND 1 to 5 did not lead to a dose-dependent decrease in male reproductive organs. Exposure to low doses (0.025 and 0.25 mg/kg) of decaBDE produced significantly decreased testicular and epididymal weight and decreased sperm count (Table 1 and Fig. 1 ). However, high-dose (2.5 mg/kg) decaBDE had no adverse effect on the male reproductive organs. Tseng et al. (2011) reported that murine maternal exposure to decaBDE by gavage administration on gestational days (GD) 0 to 17 increased the number of abnormal sperm heads in the high-dose group (1,500 mg/kg). Although our exposure method was dif- ferent, we obtained consistent and supportive results that decaBDE exposure has adverse effects on the male reproductive system in mice. Maternal and lactational exposure to very low doses (60 and 300 μg/kg) of pentaBDE decreased the sperm count in rat offspring . However, maternal exposure to even a very high dose of decaBDE (1,500 mg/kg) did not affect the sperm count in mice, although it significantly increased the number of abnormal sperm heads (Tseng et al., 2011) . This difference is attributable to the discrepancy in the molecular weights of pentaBDE and decaBDE, which influences the transfer rate from mother to offspring. While other BDEs have been found in umbilical cord blood, umbilical cords, and maternal milk in humans, decaBDE has not been detected in any of these tissues (Sjödin et al., 1999 (Sjödin et al., , 2003 McDonald, 2002; Gómara et al., 2007; Main et al., 2007; Kawashiro et al., 2008) . These findings suggest that decaBDE may not easily pass from mother to offspring, thus requiring higher doses of decaBDE to induce adverse effects. The high-dose group (2.5 mg/kg) in our study did not have lower reproductive organ weight or sperm count. However, we observed abnormal germ cells in the seminiferous tubules (Figs. 2E-G) . Tseng et al. (2011) reported abnormal testicular morphology in decaBDE-exposed mice. Fetal exposure to decaBDE from GD 0 to 17 in mice revealed an increase in the number of interstitial cells of the testes with increased vacuolization even in the 10 mg/kg group; in addition, many interstitial cells and seminiferous tubules had severe vacuolization with loss of spermatids and spermatozoa from these tubules in the high-dose group (1,500 mg/kg). The authors suggest that decaBDE possibly caused damage to the Sertoli cells, resulting in apoptosis of the germ cells. In our study, we did not observe any vacuolization in the testes sections, but we found abnormal germ cells following postnatal exposure from PND 1 to 5 in the high-dose group, too. In a previous study by Tseng et al. (2006) , mice with exposure to decaBDE from PND 21 to 70 showed no apparent dose-dependent morphological differences compared to the control group. The development of Sertoli cells is during fetal and early postnatal period (Sharpe et al., 2003) and the proliferation of Sertoli cells in mice is dramatically reduced at PND 10 and terminated by around Vol. 37 No. 5 PND15 (Joyce et al., 1993) . PND 1 to 5 includes the period of Sertoli cell proliferation. Since the role of Sertoli cells is to maintain germ cell development (Holsberger and Cooke, 2005) , the impaired development of Sertoli cells by exposure to deca-BDE may not maintain germ cells development, resulting in the occurrence of abnormal germ cells. These findings indicate that fetal and early postnatal stages of testes development may represent a specific window of susceptibility to adverse effects caused by decaBDE exposure in mice. In fish and fish gonad cells, decaBDE exposure was confirmed to cause apoptosis due to an increase in oxidative stress (Jin et al., 2010; Li et al., 2011) . Tseng et al. (2006 Tseng et al. ( , 2011 showed that fetal exposure to decaBDE or exposure to decaBDE from PND 21 to 70 increased the level of reactive oxygen species (ROS) in sperm, resulting in abnormal sperm heads. Their results suggest that decaBDE exposure affects mouse testes by inducing apoptosis via ROS. Future experiments should elucidate the molecular mechanism of apoptosis induced by decaBDE in mouse testes. Vol. 37 No. 5
Postnatal exposure from PND 1 to 5 in mice to decaBDE by subcutaneous injection reduced the expression level of CTTN. In addition, exposure to decaBDE altered the expression and phosphorylation levels of SRC, and p44/42 ERK. What are accompanied with the adverse effects seen in the lower (0.025 mg/kg) dose group? The comparisons shown in Table 3 suggest that one potential factor is the increase of pY421 CTTN/CTTN phosphorylation level. Although the phosphorylation level of pY421 CTTN/CTTN was significantly increased in all decaBDE-exposed groups, the increased phosphorylation level of pY421 CTTN/CTTN in 0.25 and 2.5 mg/kg decaBDE-exposed groups may be false because of significant reduction of the expression level of CTTN. On the other hand, the expression level of pY421 CTTN was 10% higher than control group while the expression level of CTTN in the lower (0.025 mg/kg) dose group did not differ from the control group. The reason for the increase in expression level of pY421 CTTN at the lower dose of decaBDE is not clear. SRC is considered to regulate CTTN phosphorylation (Ammer and Weed, 2008) . Given that estrogen activates SRC and ERK (Li et al., 2010; Jeng and Watson, 2011) , and decaBDE can act as estrogenic effect (Tseng et al., 2008) , decaBDE may activate SRC and p44/42 ERK in mouse testes. However, the present study did not show the SRC activation, just the reduction of SRC expression level. We need the further experiment to clarify this. Another potential factor is the CTTN phosphorylation site. The CTTN phosphorylation sites act as switches for actin assembly or disassembly in cell dynamics (Lua and Low, 2005) . Ser phosphorylation of CTTN induced by ERK enhances actin polymerization, whereas Tyr phosphorylation of CTTN induced by SRC causes actin depolymerization (Fan et al., 2004) . Our results indicate that lower-dose (0.025 mg/kg) decaBDE caused actin depolymerization by Tyr phosphorylation of CTTN and not Ser phosphorylation of CTTN via ERKs.
It is possible that actin polymerization occurred at the higher doses (0.25 and 2.5 mg/kg) due to an increase in Ser phosphorylation of CTTN. However, we found that the reduction of testicular weight and sperm in the 0.25 mg/kg decaBDE-exposed group, but not in 2.5 mg/kg decaBDE-exposed group. This may be due to the differences of ERKs activation. Phosphorylation levels of both p42 and p44 ERKs increased only in the 2.5 mg/kg decaBDE-exposed group. This finding suggests that ERKs activation may induce more pS405 CTTN phosphorylation, resulting in more enhancement of actin polymerization in the testes of the high-dose group compared to the 0.25 mg/kg decaBDE-exposed group. Thus, ERK activation by high-dose decaBDE may suppress the adverse effects on mouse testes. In contrast, pS405 CTTN phosphorylation increased without ERKs activation in the 0.25 mg/kg decaBDE-exposed group. It is possible that actin polymerization was not stronger in the 0.25 mg/kg decaBDE-exposed group compared to the 2.5 mg/kg decaBDE-exposed group, resulting in adverse effect. Taken together, our findings suggest the possibility that different mechanisms are involved in lower-dose (0.025 mg/kg) and high-dose (2.5 mg/kg) exposure. Further experiments are needed to elucidate these mechanisms in detail.
We found that the number of elongated spermatids and Sertoli cells were reduced in the lower dose (0.025 and 0.25 mg/kg) decaBDE-exposed groups ( Table 2 ). The ES is an actin-based junctional structure between Sertoli cells and germ cells in testes. The apical ES is present in the cortical portion of Sertoli cells that face elongated spermatids and is considered to regulate spermatogenesis, especially spermiation (Russell, 1977; Vogl et al., 2000; Toyama et al., 2003; Wong and Cheng, 2009 ). Large and densely stained residual bodies were observable in the lumens of seminiferous tubules (stage VIII sections) in the decaBDE-exposed groups (Supplemental Fig. 1, right  panel, arrows) . Although the differences were not significant, the incidence of such residual bodies per seminiferous tubule was higher in all dose groups than in the control group (Supplemental Fig. 1, graph) . The reduction in the number of elongated spermatids, and a slight elevation in the number of large and densely stained residual bodies in the stage VIII testicular sections, from the low-dose decaBDE group suggest failure to release spermatozoa. However, the significance of the latter finding is not clear. In male rats, treatment with EDCs such as 17β-estradiol, β-estradiol 3-benzoate, and bisphenol A by subcutaneous injection causes disruption of the apical ES (Toyama and Yuasa, 2004) . Moreover, we previously demonstrated that postnatal exposure to flutamide disrupts the apical ES and increases Tyr phosphorylation of CTTN in mouse testes (Anahara et al., 2006a (Anahara et al., , 2006b ). Taken together, we suggest that exposure of male mice to low-dose decaBDE during the postnatal period (PND 1-5) may affect the apical ES by actin depolymerization induced through increased Tyr phosphorylation of CTTN. However, further ultrastructural analysis is required to confirm this hypothesis.
We noted a reduction in the number of Sertoli cells per tubule in the low-dose (0.025 and 0.25 mg/kg) decaBDEexposed groups. This result may be attributable to the specific window of Sertoli cells development. Since Sertoli cells proliferate during fetal and early postnatal period; especially they proliferate by around PND 15 in mice (Joyce et al., 1993; Sharpe et al., 2003) , growth may have been affected by exposure during this period. Animal study show that treatment of thyroid hormone in adult rat did not show any adverse effect to Sertoli cells number (Jannini et al., 1993) . In addition, thyroid hormones, as another factor, play an important role in Sertoli cell development (Holsberger and Cooke, 2005) . Thyroid hormone imbalance due to decaBDE exposure should be considered as a possible consideration because decaBDE is reported to cause thyroid hormone imbalance (Tseng et al., 2008; Kim et al., 2009) . Animal studies show that hypothyroidism increase number of Sertoli cells (Joyce et al., 1993; Holsberger and Cooke, 2005) . In contrast, hyperthyroidism decreases number of Sertoli cells (van Haaster et al., 1993) . Thus, the reduction in the number of Sertoli cells in this study may be related to the disruption of the thyroid hormone balance. Thyroid hormone is also reported to activate SRC and ERKs in neural or rat alveolar epithelial cells (Shih et al., 2001; Cao et al., 2009) . Although the regulation of SRC and ERKs by thyroid hormone has not yet been confirmed in mouse testes, thyroid hormone may also activate SRC and ERKs in mouse testes. To clarify whether thyroid hormone levels are altered by decaBDE exposure as well as the regulation of SRC and ERKs activation by thyroid hormone in mouse testes, further experiments are necessary.
In conclusion, (1) low-dose (0.025 mg/kg) decaBDE exposure showed reduced testicular weight, sperm count, and elongated spermatid and Sertoli cell numbers, as well as induced Tyr phosphorylation of CTTN; (2) 0.25, and 2.5 mg/kg decaBDE-exposed groups decreased the expression level of CTTN compared to the control; and (3) high-dose (2.5 mg/kg) decaBDE did not affect testicular weight and sperm count, but did show an increase in the number of abnormal germ cells and Ser phosphorylation of CTTN with ERKs activation. These findings indicate that postnatal exposure to low-dose decaBDE inhibits mouse testicular development by increasing Tyr phosphorylation of CTTN. However, different mechanisms may be involved depending on the dose of decaBDE. Further toxicological experiments are required to elucidate the detailed molecular mechanisms of postnatal exposure to decaBDE on mouse testes.
